1. Central Brain Tumor Registry of the United States (CBTRUS): 2008 statistical report: primary brain tumors in the United States. Available at http://www.cbtrus.org/reports/reports.html . Accessed November 2009.
2. Stupp R, Mason WP, van den Bent MJ, et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987–996.
3. •• Stupp R, Hegi ME, Mason WP, et al.: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009, 10:459–466. This is the update of the original EORTC/NCIC study [2] that defined the standard of care for TMZ/RT with 5-year survival data.
4. Khasraw M, Bell D, Wheeler H: Long-term use of temozolomide: could you use temozolomide safely for life in gliomas? J Clin Neurosci 2009, 16:854–855.
5. Abrey LE, Louis DN, Paleologos N, et al.: Survey of treatment recommendations for anaplastic oligodendroglioma. Neuro Oncol 2007, 9:314–318.